Mitchell Henry
Plastic and Reconstructive Surgery · Lincoln, NENPI 1215927181
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,891 of the $2,329 with a category attached, or 81.2%. 14 manufacturers reported payments, led by Sientra, Inc. at 41.9% of the total. Reporting peaked in 2022 at $1,158 and has fallen 86.5% since, to $156 in 2025.
Across 41 payments — averaging $56.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sientra, Inc.$975
- Straumann USA LLC$502
- Integra Lifesciences Corporation$377
- RTI Surgical, Inc$125
- Acera Surgical, Inc.$108
- Motiva USA, LLC$63
- plus $179 from 8 others
What the payments were for
- Food & beverage$1,89181%
- Gifts$1125%
- Other$32614%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sientra, Inc. | 17 | $975 |
| Straumann USA LLC | 7 | $502 |
| Integra Lifesciences Corporation | 2 | $377 |
| RTI Surgical, Inc | 1 | $125 |
| Acera Surgical, Inc. | 4 | $108 |
| Motiva USA, LLC | 1 | $63 |
| Keystone Dental Inc. | 1 | $57 |
| AbbVie | 2 | $30 |
| Medtronic | 1 | $21 |
| Vertex | 1 | $21 |
| Innovation Technologies Inc | 1 | $16 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
| Apyx Medical Corporation | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few plastic and reconstructive surgery providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Chlorhexidine Gluconate | 14 | $29 |
| Amoxicillin | 20 | $13 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Lincoln
- Cassidy MitchellLincoln$2K
- R BryantLincoln$0
- Andrew HollinsOmaha$12K
- Amanda DawsonOmaha$5K
- Nagi AyoubOmaha$4K
- Jordan BloughOmaha$3K
- Brian BiggerstaffOmaha$2K
- Joel AtchisonKearney$735
- Rita SticeOmaha$596
- Jeffrey PoppOmaha$231
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.